WASHINGTON - The House Republican leadership plans to roll out revised versions of FDA reform bills this week in a bid to come up with legislation that the FDA feels it can live with, if not embrace.

The Commerce Committee, which is considering separate FDA reform bills dealing with drugs and biologics, devices, and food, is working under strict temporal constraints - time is running short to get legislation enacted, work out a compromise with the Senate, and get a bill to President Clinton that he would be willing to sign.